Redressing the Patent Imbalance in Genetic Testing

Redressing the Patent Imbalance in Genetic Testing

In one of the most highly anticipated decisions emanating from the apex Court in the US in recent times, the US Supreme Court in Association for Molecular Pathology v Myriad Genetics Inc was asked to consider, in the main, the patentability of a naturally occurring gene sequence which had been specifically isolated from the human […]